QuantRx Biomedical Corporation (QTXB)

[ALERTS100%to10000%GAIN]

About QUANTRX BIOMEDICAL CORPORATION (OTCMKTS:QTXB)

QuantRx Biomedical Corporation is engaged in developing and commercializing its miniform pad (PAD)-based products for the over-the-counter markets for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses and other medical needs. It is focused on developing and commercializing genomic diagnostics for the laboratory market, based on its PadKit technology. Its platforms include inSync, Unique, PadKit, and original equipment manufacturer branded over-the-counter and laboratory testing products based on its PAD technology. Its PAD products are based on the non-woven disposable absorbent pad technology, with products for aiding the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, the over-the-counter catamenial markets, and other medical needs, including diagnostic sampling products, which enable self-collection and around the world transport for indications, such as cancers, premature delivery, and genomic testing.